Obstetrics Flashcards
Normal umbilical artery gas values
pH 7.28 (+- 0.05)
pCO2 49 +- 8.4
pO2 18.0 +- 6.2
HCO3 22.3 +- 2.5
Base deficit 4 +- 3
Neonatal metabolic acidosis labs
pH <7.0, base deficit 12 or greater
Effects of radiation exposure by gestational age
0-4w all or nothing
4-11w multi-organ systems
12-15w CNS
Antiphospholipid syndrome diagnostic criteria
Meets one clinical and one lab criteria
Clinical:
- vascular thrombosis
- pregnancy morbidity (unexplained fetal death after 10w, preterm birth before 34w b/c of preE/eclampsia/placental insufficiency, 3+ consecutive SAB before 10w without other cause)
Lab: +Ab on 2 occasions 12+ weeks apart
- lupus AC, anticardiolipin med-high titer, anti-beta2 glycoprotein >99%ile)
CMV in pregnancy
- most severe fetal effects in first trimester, but most commonly transmitted in third trimester (40-72% vs. 30%)
- up to 25% of babies with sequelae
- HSM, jaundice, petechiae, thrombocytopenia, hearing loss
Congenital varicella US findings
Hydrops
Hyperechogenic foci in liver/bowel
Cardiac malformations
Limb deformities
Microcephaly
FGR
- most likely transmitted in 2nd tri, least likely in 3rd, overall unlikely (0.4-2%)
TTTS Quintero staging
I: oli-poly (>8 and <2 cm in donor)
II: bladder absent in donor
III: abnormal dopplers (AEDF or reversal)
IV: hydrops
V: demise
Diseases with highest risk of stillbirth
out of 1000 pregnancies
SLE (40-150)
Renal disease (15-200)
Cholestasis (12-30)
Prior stillbirth (9-20)
Late term pregnancy (14-40)
Multiple gestation (12-34)
FGR (10-47)
Diabetes (6-35), worse when on meds
Overall stillbirth rate 6.4/1000
Di-di twin timing, diagnosis
Cleavage in days 1-3 (morula stage)
Can be mono or dizygotic
Twin peak/lambda sign
Monochorionic timing, diagnosis
Cleavage in days 4-8 (dichorionic, blastocyst) or 8-13 (implanted blastocyst, monochorionic)
Thin dividing membrane (max 2mm)
Right angle between membrane and placenta
Fetal echo needed (risk of CHD)
Growth/fluid every 4 weeks
Antenatal testing at 32w
TTTS screening q2w starting at 16w
Recommended weight gain in pregnancy
BMI <18.5 28-40
18.5-24.9 25-35
25-29.9 15-25
>30 11-20
Obesity risks in pregnancy
Maternal: C-section, VTE, wound complications, endometritis, PPD, preE, GDM, OSA
Fetal: SAB, stillbirth, congenital anomalies (NTD, cardiac, orofacial/limb), indicated PTD, macrosomia, childhood morbidities (metabolic syndrome/obesity)
Congenital rubella findings (US and postnatal)
US: cataracts, pulmonary a. stenosis, microcephaly, radiolucent bone disease
After birth: PDA, intellectual disabilities, sensorineural deafness
Tetracycline fetal effects
Teeth staining
Cerebral palsy imaging findings
Periventricular leukomalacia
Erb palsy
C5-6
Waiters tip
Klumpke palsy
C8-T11
Claw hand
Congenital varicella findings
Skin scarring
Limb hypoplasia
Chorioretinitis
Microcephaly
High neonatal death rate when transmitted within 5d before to 48h after delivery
Congenital CMV findings
Jaundice
Petechiae
Thrombocytopenia
HSM
FGR
Myocarditis
Nonimmune hydrops
Congenital hearing loss
30% of severely infected infants die, 65-80% of survivors have neurologic morbidity